The mutations leading to the inactivation of both alleles of PARP1 and Rad54 genes resulted in proliferation arrest and senescence induction in cancer cells through activation of the TP53-p21 pathway and inhibited tumor growth [94]. The gene discussed is CDKN1A; the disease is cancer.